stroke

News

Roche ends the 30-year US hiatus in new stroke drugs

Genentech has won FDA approval for its clot-buster TNKase as a treatment for acute ischaemic stroke, after almost abandoning the project in 2023.

News

Novartis builds in cardiovascular with $3.1bn Anthos buy

Novartis has agreed to buy Anthos from private equity firm Blackstone for $3.1 billion, taking Factor XI inhibitor abelacimab back in-house.

R&D

Innovative sublingual medication for improved stroke care

Stroke poses a major threat to public health, and this threat is predicted to worsen in the years to come.

News

iRhythm wearable heart monitor raises AFib diagnoses by 52%

Screening people in primary care with a wearable heart monitor developed by iRhythm was able to increase diagnoses of atrial fibrillation (AFib) by 52%, although it did not result in a redu

Digital

Embracing innovation to drive clinical change in UK stroke c...

Medical technology (MedTech) companies go through a vigorous process to introduce their solutions into a clinical environment.

News

NICE says Boehringer stroke drug 'could save millions'

In new guidance, NICE has cleared NHS use of Boehringer Ingelheim's clot-busting therapy Metalyse as a treatment for acute ischaemic stroke in adults.

Roche ends the 30-year US hiatus in new stroke drugs

Novartis builds in cardiovascular with $3.1bn Anthos buy

Innovative sublingual medication for improved stroke care

iRhythm wearable heart monitor raises AFib diagnoses by 52%

Embracing innovation to drive clinical change in UK stroke c...

NICE says Boehringer stroke drug 'could save millions'

Agios mulls early FDA filing for sickle cell therapy

Using AI-driven synthetic personas to take your insights fur...

stroke

Editor's Picks